cognitive

Selank

Also known as: TP-7, Selanc
FDA: Not FDA-approved WADA: Not listed

Selank is a synthetic heptapeptide derived from tuftsin (a naturally occurring immunomodulatory tetrapeptide Thr-Lys-Pro-Arg) with a C-terminal Pro-Gly-Pro extension that enhances metabolic stability and CNS penetration. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, it was approved in Russia for the treatment of generalized anxiety disorder (GAD) and neurasthenia. Selank provides anxiolytic effects comparable to benzodiazepines but without sedation, cognitive impairment, or addiction potential. It also possesses immunomodulatory and nootropic properties, modulating IL-6 production and enhancing enkephalin stability. For educational purposes only. Not medical advice. Selank operates through multiple neurochemical and immune pathways: 1. GABAergic

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight 751.87 Da
Half-life ~2-5 minutes rapid
CAS number
Route Intranasal
02

Mechanism

Synthetic tuftsin analog with C-terminal Pro-Gly-Pro extension — modulates GABAergic system, stabilizes enkephalins, regulates IL-6 and monoamine metabolism, anxiolytic without sedation

03

Dosing

DOSE RANGE 200–400 mcg
FREQUENCY 1-3x daily
CYCLE LENGTH 2-4 weeks on, 2 weeks off

Intranasal spray. Often used with Semax. Russian clinical dose: 200-400 mcg/day. N-Acetyl Selank Amidate (NASA) is a more potent derivative.

04

Research summary

Study Type Year Key Finding
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions Review 2026 Selank identified among neuroactive peptides enhancing BDNF and HGF/c-Met pathways
Pathophysiological aspects of primary Sjogren's disease: From epithelial activation to systemic autoimmunity Review 2026 Sjogren's disease involves epithelial dysregulation, innate immune activation, and adaptive immune response
Selank GABAergic and Enkephalin Mechanism Summary Mechanism summary 2008-2015 Selank allosterically modulates GABA-A receptors for anxiolytic effect
05

Stacking & interactions

Cognitive + anxiolytic combo — Selank calms, Semax stimulates

Anxiolytic + immune modulation

Anxiolytic + gut-brain axis healing

Stacks containing Selank

28-day resets featuring Selank

06

Sourcing

Current prices

Updated today

10mg

20mg

Only vendor stocking this size on the VialBase roster.

30mg

Only vendor stocking this size on the VialBase roster.

Size unspecified

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs Positive rep

Save 20% with code VIALBASE at checkout

Stocks this compound Third-party tested Public COAs Positive rep

Save 15% with code VIALBASE at checkout

Stocks this compound Third-party tested Public COAs Positive rep

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

Also vetted at
What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
DURING CYCLE
  • CMP (if extended use beyond 30 days)
POST-CYCLE
  • CMP
Safety & Regulatory Status
FDA STATUS Not FDA-approved. Approved in Russia for anxiety and neurasthenia
WADA STATUS Not listed

Regulatory status for Selank may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.

References

  1. Rahman OF, Lee SJ, Seeds WA. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev (2026). PMID: 41490200
  2. Ritter J, Dorner T. Pathophysiological aspects of primary Sjogren's disease: From epithelial activation to systemic autoimmunity. Z Rheumatol (2026). PMID: 41848778
  3. Compiled from multiple Russian studies. Selank GABAergic and Enkephalin Mechanism Summary. Various (2008-2015).